Strides Pharma on FY20 business outlook
  • 5 years ago
The quarter on quarter growth for US business which was on a low base may not be sustainable going forward but growth in high teens would be achievable considering they have growth over 80 percent in the last fiscal from US, said Arun Kumar, MD & Group CEO, Strides Pharma.
Recommended